31843450 26302233 30140713 26858964 29878653 25558460 31140323 27695454 29225598 26603344 28284982 27257611 30581888 27658524 31968213 33183859 33742707 25745178 28961410 34853797 27061380 24106222 30210756 33651716 24550919 28888664 28552407 2819742 - Search Results

Year	Number of Results
2013	1
2014	13
2015	11
2016	13
2017	19
2018	10
2019	14
2020	11
2021	8
2022	1

1

A Molecular Revolution in the Treatment of Hemophilia.

Butterfield JSS, Hege KM, Herzog RW, Kaczmarek R. Butterfield JSS, et al. Mol Ther. 2020 Apr 8;28(4):997-1015. doi: 10.1016/j.ymthe.2019.11.006. Epub 2019 Nov 13. Mol Ther. 2020. PMID: 31843450 Free PMC article. Review.

2

Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.

Su J, Zhu L, Sherman A, Wang X, Lin S, Kamesh A, Norikane JH, Streatfield SJ, Herzog RW, Daniell H. Su J, et al. Biomaterials. 2015 Nov;70:84-93. doi: 10.1016/j.biomaterials.2015.08.004. Epub 2015 Aug 5. Biomaterials. 2015. PMID: 26302233 Free PMC article.

3

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs.

Sun J, Shao W, Chen X, Merricks EP, Wimsey L, Abajas YL, Niemeyer GP, Lothrop CD, Monahan PE, Samulski RJ, Nichols TC, Li C. Sun J, et al. Mol Ther Methods Clin Dev. 2018 Aug 4;10:257-267. doi: 10.1016/j.omtm.2018.07.011. eCollection 2018 Sep 21. Mol Ther Methods Clin Dev. 2018. PMID: 30140713 Free PMC article.

4

Targeted approaches to induce immune tolerance for Pompe disease therapy.

Doerfler PA, Nayak S, Corti M, Morel L, Herzog RW, Byrne BJ. Doerfler PA, et al. Mol Ther Methods Clin Dev. 2016 Jan 27;3:15053. doi: 10.1038/mtm.2015.53. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 26858964 Free PMC article. Review.

5

Haemophilia gene therapy: From trailblazer to gamechanger.

Evens H, Chuah MK, VandenDriessche T. Evens H, et al. Haemophilia. 2018 May;24 Suppl 6:50-59. doi: 10.1111/hae.13494. Haemophilia. 2018. PMID: 29878653 Review.

6

Development of Gene Transfer for Induction of Antigen-specific Tolerance.

Sack BK, Herzog RW, Terhorst C, Markusic DM. Sack BK, et al. Mol Ther Methods Clin Dev. 2014 Apr 30;1:14013. doi: 10.1038/mtm.2014.13. Mol Ther Methods Clin Dev. 2014. PMID: 25558460 Free PMC article.

7

TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.

Butterfield JSS, Biswas M, Shirley JL, Kumar SRP, Sherman A, Terhorst C, Ling C, Herzog RW. Butterfield JSS, et al. Hum Gene Ther Methods. 2019 Jun;30(3):81-92. doi: 10.1089/hgtb.2019.013. Hum Gene Ther Methods. 2019. PMID: 31140323 Free PMC article.

8

Induction of Hematopoietic Microchimerism by Gene-Modified BMT Elicits Antigen-Specific B and T Cell Unresponsiveness toward Gene Therapy Products.

Martinet J, Bourdenet G, Meliani A, Jean L, Adriouch S, Cohen JL, Mingozzi F, Boyer O. Martinet J, et al. Front Immunol. 2016 Sep 15;7:360. doi: 10.3389/fimmu.2016.00360. eCollection 2016. Front Immunol. 2016. PMID: 27695454 Free PMC article.

9

Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.

Sherman A, Biswas M, Herzog RW. Sherman A, et al. Front Immunol. 2017 Nov 24;8:1604. doi: 10.3389/fimmu.2017.01604. eCollection 2017. Front Immunol. 2017. PMID: 29225598 Free PMC article. Review.

10

Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.

Doerfler PA, Todd AG, Clément N, Falk DJ, Nayak S, Herzog RW, Byrne BJ. Doerfler PA, et al. Hum Gene Ther. 2016 Jan;27(1):43-59. doi: 10.1089/hum.2015.103. Hum Gene Ther. 2016. PMID: 26603344 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results